Use of Dupilumab in AD
Expert dermatologists review the use of dupilumab for the treatment of AD, focusing on the once-monthly shot as a factor in selection.
Patient Case #1: AD Treatment Approaches
Elizabeth Swanson, MD, and Brad Glick, DO, MPH, FAOCD, share treatment approaches for pediatric patients with AD.
Resident Training in Plaque Psoriasis
Nicholas Brownstone, MD, comments on how newer treatments in plaque psoriasis can impact residency training.
Topical vs Systemic Therapy in Plaque Psoriasis
Dawn L. Sammons, DO, FAOCD, FAAD, shares her approach to using topical vs systemic therapy in plaque psoriasis, focusing on patient preference as the driving factor for treatment selection.
Key Takeaways and Discussion Highlights
Drs Justine Cohen and Brent Moody provide their key takeaways and panel discussion highlights related to the management of patients with basal cell carcinoma.
Expert Insights into Duration of Treatment for Hedgehog vs Immunotherapy
An expert in dermatology shares her insights into the duration of treatment and dose adjustments for systemic treatments in patients with basal cell carcinoma.
Systemic Treatment Considerations for Basal Cell Carcinoma
Dr Justine Cohen discusses her approach to systemic treatment selection in her patients with basal cell carcinoma; highlighting the importance of individualizing the treatment plan.
Insights into Non-Surgical Approaches to Basal Cell Carcinoma
Justine Cohen, DO and Brent Moody M.D., F.A.C.P., F.A.A.D, comment on which patients would be appropriate for non-surgical treatment options in the management of their basal cell carcinoma.
Impact of PP Comorbidities
Tj Chao, MPAS, and Lauren Miller, MPAS, highlight comorbidities that caregivers should consider when treating patients with plaque psoriasis (PP).
Factors to Consider when Treating PP
Lauren Miller, MPAS, and Tj Chao, MPAS, discuss key factors to consider for plaque psoriasis (PP) treatment.
Patient Case #1: 6-Year-Old Male Patient With Moderate AD
Expert dermatologists present and share initial impressions of a patient case for a 6-year-old male with AD, highlighting the impact of sleep deprivation.
Switching Treatment in AD
Jonathan I Silverberg, MD, PhD, MPH; Elizabeth Swanson, MD; Brad Glick, DO, MPH, FAOCD; and Andrew Blauvelt, MD, MBA, review factors that lead to switching therapies in AD, focusing on monotherapies vs combination therapy.
Expert Insights into the Importance of Active Components in Acne Treatments
An expert in dermatology shares his opinion on the multiple formulations of isotretinoin and the importance of generic vs brand compositions.
Novel Approach to Sebum Production
Dr Leon Kircik, discusses the novel treatment Clascoterone cream 1%, an androgen receptor agonist, and the utility of this treatment in the management of acne.
Expert Opinion on the Utility of Guidelines in Patient Care
Leon Kircik, MD, shares his opinion on the role and use of treatment guidelines by healthcare practitioners in the management of their patients.
The Role of Physician Assistants in PP Management
Experts discuss the role and importance of physician assistants in the treatment and care of plaque psoriasis (PP).
Overview of PP
Tj Chao, MPAS, and Lauren Miller, MPAS, discuss the symptoms of plaque psoriasis (PP) and why it may be difficult to diagnose.
Use of Topical Treatment in Plaque Psoriasis
Brad Glick, DO, FAOCD, highlights topical therapy as a targeted treatment of plaque psoriasis.
The Pathogenesis of Plaque Psoriasis
Benjamin Lockshin, MD, FAAD, comments on how the evolution of the pathophysiology of plaque psoriasis has led to more targeted therapies to treat the disease.
Time to Treatment Response in AD Treatment Selection
Experts in dermatology comment on how often quickness of response to therapy determines treatment selection for teenaged patients with AD.